lynozyfic
Generic: linvoseltamab-gcpt
Labeler: regeneron pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
lynozyfic
Generic Name
linvoseltamab-gcpt
Labeler
regeneron pharmaceuticals, inc.
Dosage Form
INJECTION, SOLUTION, CONCENTRATE
Routes
Active Ingredients
linvoseltamab 5 mg/2.5mL
Manufacturer
Identifiers & Regulatory
Product NDC
61755-054
Product ID
61755-054_d82c287f-a94e-4831-9991-4742cdd17348
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA761400
Listing Expiration
2026-12-31
Marketing Start
2025-07-02
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
61755054
Hyphenated Format
61755-054
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lynozyfic (source: ndc)
Generic Name
linvoseltamab-gcpt (source: ndc)
Application Number
BLA761400 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/2.5mL
Packaging
- 1 VIAL, SINGLE-DOSE in 1 CARTON (61755-054-01) / 2.5 mL in 1 VIAL, SINGLE-DOSE (61755-054-00)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "d82c287f-a94e-4831-9991-4742cdd17348", "openfda": {"unii": ["M3CPC50MZS"], "rxcui": ["2719483", "2719490", "2719494", "2719497"], "spl_set_id": ["e9fd0739-1b3f-4b8b-824a-1f0a902384d3"], "manufacturer_name": ["Regeneron Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (61755-054-01) / 2.5 mL in 1 VIAL, SINGLE-DOSE (61755-054-00)", "package_ndc": "61755-054-01", "marketing_start_date": "20250702"}], "brand_name": "LYNOZYFIC", "product_id": "61755-054_d82c287f-a94e-4831-9991-4742cdd17348", "dosage_form": "INJECTION, SOLUTION, CONCENTRATE", "product_ndc": "61755-054", "generic_name": "linvoseltamab-gcpt", "labeler_name": "Regeneron Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LYNOZYFIC", "active_ingredients": [{"name": "LINVOSELTAMAB", "strength": "5 mg/2.5mL"}], "application_number": "BLA761400", "marketing_category": "BLA", "marketing_start_date": "20250702", "listing_expiration_date": "20261231"}